Solid tumors harboring A TP53 Y220C mutation

Clinical trials for Solid tumors harboring A TP53 Y220C mutation explained in plain language.

Never miss a new study

Get alerted when new Solid tumors harboring A TP53 Y220C mutation trials appear

Sign up with your email to follow new studies for Solid tumors harboring A TP53 Y220C mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill targets hard-to-treat cancers with rare gene mutation

Disease control Recruiting now

This study tests a new pill called GenSci128 in people whose advanced solid tumors have a specific change in the TP53 gene (Y220C). The main goals are to check the pill's safety, find the best dose, and see if it can shrink tumors. About 82 participants will take the pill by mout…

Matched conditions: SOLID TUMORS HARBORING A TP53 Y220C MUTATION

Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC

Solid tumors harboring A TP53 Y220C mutation

Get alerted when new Solid tumors harboring A TP53 Y220C mutation trials appear

New pill targets hard-to-treat cancers with rare gene mutation